Home › Medical Devices
Medical Devices Market Research Reports & Consulting
Market Reports
| Title | Published | Price | TOC Available |
|---|---|---|---|
Wearable Injectors Market by Type (On-Body and Off-Body injectors (Infusion Pump Devices)), Therapy (Immuno-oncology, Diabetes, Cardiovascular diseases, Parkinson's disease, Thalassemia, Primary Immunodeficiency Disease) - Global Forecast to 2023The global wearable injectors market is projected to reach USD 9.41 billion by 2023 from USD 5.57 billion in 2018, at a CAGR of 11.1% during the forecast period. The growth of this market is primarily driven by the growing prevalence of chronic diseases (such as cancer, diabetes, and CVD); favorable reimbursement scenario in major markets; and technological advancements in injector devices. The key players in the global wearable injectors market are Amgen (US), Medtronic (Ireland), Insulet Corporation (US), Tandem Diabetes Care (US), United Therapeutics Corporation (US), Valeritas (US), and SteadyMed Therapeutics (US). The other prominent players in this market are Ypsomed (Switzerland), Becton, Dickinson and Company (US), Enable Injections (US), Sensile Medicals (Switzerland), and Bespak (UK). |
October 2018 | $ 5650 |
|
Negative Pressure Wound Therapy Market by Device Type (Conventional & Single-use NPWT, Accessories), Wound Type (Surgical & Traumatic, Diabetic Foot, Pressure, Venous Leg Ulcers and Burns), End User (Hospitals, Homecare) - Global Forecast to 2023The negative pressure wound therapy (NPWT) devices market is expected to reach USD 2.72 billion by 2023 from USD 2.11 billion in 2018, at a CAGR of 5.2%. Growing prevalence of diabetes, increasing spending on chronic and surgical wounds, government initiatives to prevent SSIs, and high rate of cesarean sections in elderly mothers leading to increasing post-operative use of NPWT devices are some of the factors expected to drive market growth during the forecast period. Some of the major players in Acelity (US), Smith & Nephew (UK), Mölnlycke Health Care AB (Sweden), Cardinal Health (US), ConvaTec (UK), and DeRoyal (US), Lohmann & Rauscher (German), Talley Group (UK), Medela (Switzerland), and Genadyne (US) amongst others. |
October 2018 | $ 5650 |
|
Hepatitis Test Solution/Diagnosis Market by Disease Type (Hepatitis B, HCV, HAV, HDV), Technology (ELISA, RDT, PCR, Transcription Mediated Amplification), End User (Hospitals, Diagnostic Laboratories, Blood Banks, Nursing Homes) - Global Forecast to 2023The global hepatitis test solution/diagnosis market is projected to reach USD 3.37 billion by 2023 from USD 2.66 billion in 2018, at a CAGR of 4.9% during the forecast period. This market is primarily driven by factors such as the high burden of hepatitis worldwide, increasing number of blood transfusions and donations, benefits offered by PoC instruments & kits, and awareness initiatives. Emerging markets such as China, India, Brazil, and Africa are expected to offer lucrative growth opportunities for the players in this market. However, the high cost of NAT tests and a lack of mandate for NAT in developing countries are expected to restrain the growth of this market during the forecast period. The key players operating in this market include Abbott Laboratories (US), Roche (Switzerland), Bio-Rad (US), Siemens (Germany), DiaSorin (Italy), QIAGEN (Netherlands), bioMérieux (France), Danaher (US), and Grifols (Spain). |
October 2018 | $ 5650 |
|
Surgical Suture Market by Product (Automated Suturing Device (Disposable, Reuse), Suture Thread (Natural, Nylon, Prolene, Stainless Steel, Silk)), Application (Cardiac, Gynae, Ophthalmic, Orthopedic), End User (Hospital, Clinic) - Global Forecast to 2023The global surgical sutures market is projected to reach USD 5.02 billion by 2023 form USD 3.86 billion by 2018, at a CAGR of 5.4% from 2018 to 2023. The global market for surgical sutures is witnessing steady growth primarily due to the increasing number of surgical procedures conducted, globally. The favorable reimbursement scenario for a number of surgical procedures and the launch of advanced sutures are further contributing to the market growth. The report segments the surgical sutures market by product, type, application, end user, and region. The surgical sutures market is marked by the presence of several established as well as emerging players, such as Ethicon, Inc. (US), Medtronic plc (Ireland), B.Braun Melsungen AG (Germany), Smith& Nephew plc (UK), Boston Scientific Corporation (US), Péters Surgical (France), DemeTECH Corporation (US), Internacional Farmacéutica (Mexico), Sutures India (India), EndoEvolution, LLC. (US), Apollo Endosurgery, Inc. (US), Surgical Specialties Corporation (US), and Mellon Medical B.V. (Netherlands). |
October 2018 | $ 5650 |
|
Flexible & Semi-rigid Ureteroscopy Market by Product (Flexible Ureteroscopes, Semi-rigid Ureteroscopes), Application (Urolithiasis, Urinary Stricture, Kidney Cancer), End User (ASCS, Hospitals), and Region (US, Canada, Asia, Europe) - Global Forecast to 2023The flexible & semi-rigid ureteroscopy market is expected to reach USD 1,054.1 million by 2023 from USD 809.6 million in 2018, at a CAGR of 5.4%. The high incidence of urolithiasis across the globe is a major factor driving the growth of this market. The rapidly increasing geriatric population, technological advancements in devices, and improving hospital infrastructures are the other major factors that are expected to support the growth of the flexible & semi-rigid ureteroscopy market in the coming years. Some of the major players operating in this market are Olympus (Japan), Stryker (US), Boston Scientific (US), KARL STORZ (Switzerland), Richard Wolf (Germany), ELMED Medical Systems (Turkey), Rocamed (France), Maxer Endoscopy (Germany), ProSurg (US), and Vimex Endoscopy (Poland). To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the industrial gearbox market. These players include Siemens AG (Germany), Bonfiglioli Italia S.P.A (Italy), Bondioli & Pavesi (Italy), Sew-Eurodrive (Germany), and Dana Brevini (Italy). |
September 2018 | $ 5650 |
|
Ultrasound Probe Disinfection Market by Product (Instrument, Service, Consumables (High-level Disinfectants, Disinfectant Wipes & Spray, Enzymatic Detergent)), Probe Type (Linear & Endocavity Transducer), End User (Hospitals)-Global Forecast to 2023The global ultrasound probe disinfection market is projected to reach USD 819.1 million by 2023 from USD 314.1 million in 2018, at a CAGR of 21.1%. The growth of this market is driven by factors such as the increasing number of ultrasound imaging procedures, rising incidence of hospital-acquired infections due to the improper reprocessing of ultrasound probes, increasing adoption of high-level disinfection systems for critical and semi-critical ultrasound probes, and technological advancements in ultrasound probes. |
September 2018 | $ 5650 |
|
Medical Aesthetics Market Product (Botox, Dermal Filler, Liposuction, Cellulite Reduction, Fat Reduction, Skin Tightening, Breast Implant, Tattoo Removal, Thread Lift), End User (Clinic, Medical Spa, Hospital, Beauty Center) - Global Forecast to 2023The global medical aesthetics market is projected to reach USD 17.07 billion by 2023 from USD 10.30 billion in 2018, at a CAGR of 10.6%. The growing adoption of minimally invasive and noninvasive aesthetic procedures, rising adoption among geriatric individuals, increasing public awareness about cosmetic procedures, the availability of technologically advanced & user-friendly products, and the increasing demand for aesthetic treatments among men are the key factors driving the growth of this market. On the other hand, market growth is limited to a certain extent by factors such as the clinical risks and complications associated with medical aesthetic procedures and the increasing availability and adoption of alternative beauty and cosmetic products. The major players operating in the medical aesthetics market are Allergan, plc (Ireland), Alma Lasers, Ltd. (Israel), Anika Therapeutics (US), Cutera, Inc. (US), Cynosure (US), El.En. S.p.A. (Italy), Fotona d.o.o. (Slovenia), Nestlé S.A. (Switzerland), Johnson & Johnson (US), Merz Pharma GmbH & Co. KGaA (Germany), Medytox, Inc. (South Korea), Sientra, Inc. (US), Sinclair Pharma plc (UK), Syneron Medical, Ltd. (US), and Valeant Pharmaceuticals International, Inc. (US). |
September 2018 | $ 5650 |
|
Capnography Equipment Market by Product (Capnometer (Multiparameter, Standalone, Handheld, Conventional), Accessories), Technology (Mainstream, Sidestream), Application (Cardiac Care, Trauma, Emergency Care), End User (Hospital) - Global Forecast to 2023The global capnography equipment market is projected to reach USD 366.5 million by 2023 from USD 297.1 million in 2018, at a CAGR of 4.3%. Factors such as the development of portable/point-of-care capnography devices, clinical benefits of capnography equipment over pulse oximetry, increasing number of surgeries, and the evolving guidelines related to the clinical use of capnography are expected to drive the demand for capnography equipment during the study period. As of 2017, the various product segments considered in the capnography equipment market are dominated by NIHON KOHDEN (Japan), Medtronic (Ireland), Smiths Group (UK), and Masimo Corporation (US). These companies accounted for a major share of the global capnography equipment market in 2017. |
September 2018 | $ 5650 |
|
Rapid Microbiology Testing Market by Method (Growth, Viability), Product (Automated Microbial Identification & AST System, PCR, Reagent), Application (Clinical Diagnosis, Environmental), End User (Labs, Hospitals, Industry) - Global Forecast to 2023The global rapid microbiology testing market is expected to USD 5.09 billion by 2023 from USD 3.45 billion in 2018, growing at a CAGR of 8.1%. Growth in the rapid microbiology testing market can be attributed to factors such as the rising prevalence of infectious diseases; ongoing technological advancements; increasing food safety concerns; increased funding, research grants, and public-private investments; and increasing awareness about rapid microbiology testing. The major players operating in the rapid microbiology testing market include bioMérieux SA (France), Danaher Corporation (US), and Becton, Dickinson and Company (US), among others. |
September 2018 | $ 5650 |
|
Patient Temperature Monitoring Market by Product (Wearable, Non-invasive, Continuous Core, Digital, Invasive Monitors), Site (Skin, Tympanic, Rectal), Application (Fever, Hypothermia, Anesthesia), End User (Hospitals, Blood Banks) - Global Forecast to 2023The patient temperature monitoring market is projected to reach USD 3.21 billion by 2023 from USD 2.55 billion in 2018, at a CAGR of 4.7% during the forecast period. Factors such as rising prevalence of infectious diseases, increasing geriatric and pediatric population, increasing number of surgical procedures, growing number of blood transfusion procedures, rising awareness about continuous temperature monitoring, and increasing demand for advanced temperature monitoring devices are driving the growth of the market. The major players operating the global patient temperature monitoring market are 3M (US), Cardinal Health (US) Koninklijke Philips (Netherlands), Hill-Rom Holdings (US), Drägerwerk (Germany), Terumo Corporation (Japan), Masimo Corporation (US), Microlife (Taiwan), Braun GmbH, and American Diagnostic Corporation (US). |
September 2018 | $ 5650 |
|
Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation (Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2023The global hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%. Growth in this market is driven by the increasing number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries. In addition, the emerging markets and growth in the number of hospitals and surgical centers are expected to offer further growth opportunities for players operating in the hemostats market during the forecast period. The major players in the hemostats market include CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany). |
September 2018 | $ 5650 |
|
Structural Heart Devices Market by Product (Heart Valve Devices (Transcatheter and Surgical), Occluders and Delivery Systems, Annuloplasty Rings, and Accessories), Procedure (Replacement and Repair) - Global Forecast to 2023The global structural heart devices market is projected to reach USD 15.08 billion by 2023 from USD 9.28 billion in 2018, at a CAGR of 10.2% during the forecast period. The rising prevalence of structural heart diseases, regulatory approvals for new and advanced structural heart devices, favorable reimbursement scenario for structural heart procedures & devices, and increasing awareness about structural heart diseases are the major factors driving the growth of the structural heart devices market. However, low affordability and inaccessibility of cardiac surgeries in developing countries are expected to restrain the growth of this market in the coming years. In addition, a dearth of skilled personnel may affect overall procedural volumes and serve to slow the pace of market growth during the forecast period. Edwards Lifesciences Corporation (US), Medtronic plc (Ireland), Abbott (US), Boston Scientific Corporation (US), and LivaNova plc (UK) are the key players in the structural heart devices market. The other players in this market are CryoLife, Inc. (US), Micro Interventional Devices, Inc. (US), Braile Biomédica (Brazil), Lepu Medical Technology (Beijing) Co., Ltd. (China), and TTK Healthcare Limited (India). |
September 2018 | $ 5650 |
|
Digital X-ray Market by Application (Radiography, Orthopedic, Cardiovascular, Fluoroscopy, Chest), Technology (Direct, Computed Radiography), Portability (Handheld, Mobile), System (Retrofit, New), End User (Diagnostic Center, Hospital), Price - Global Forecast to 2023The digital X-ray market is expected to reach USD 13.04 billion by 2023 from USD 8.68 billion in 2018, at a CAGR of 8.5%. Factors such as increasing geriatric population and the subsequent growth in global disease incidence, favorable regulations and government initiatives & investments, the advantages of digital X-ray systems, and technological advancements and product development are driving the digital X-ray market. The digital X-ray market is highly competitive with the presence of several small and big players. Some of the players in the digital X-ray market are Canon Inc. (Japan), Carestream Health (US), Fujifilm Corporation (Japan), GE Healthcare (US), Hitachi Ltd. (Japan), Hologic, Inc. (US), Philips Healthcare (Netherlands), Shimadzu Corporation (Japan), Siemens Healthineers (Germany), Konica Minolta, Inc. (Japan), Samsung Medison Co., Ltd. (Korea), and Agfa Gevaert (Belgium). |
September 2018 | $ 5650 |
|
Energy Efficient Glass Market by Coating (Hard Coat, Soft Coat), Glazing (Single Glazing, Double Glazing, Triple Glazing), Application (Building & Construction, Automotive, Solar Panel), and Region- Global Forecast to 2023The global energy efficient glass market is estimated to be USD 25.11 billion in 2018 and is projected to reach USD 32.02 billion by 2023, at a CAGR of 5.0% between 2018 and 2023. The increased demand for energy efficient glass in the building & construction, automotive, and solar panel industries is expected to drive the energy efficient glass market.Companies such as Saint-Gobain S.A. (France), Nippon Sheet Glass Co., Ltd. (Japan), AGC Inc. (Japan), SCHOTT AG (Germany), Guardian Glass, LLC. (US), Sisecam Group (Turkey), and Vitro Architectural Glass (US) are the leading players in the energy efficient glass market |
September 2018 | $ 5650 |
|
Veterinary Equipment and Disposables Market by Product (Consumables, Anesthesia Machines, Ventilators, Patient Monitoring, Oxygen Masks, Infusion Pumps), Animal (Cats, Dogs, Equines, Bovines), End User (Hospitals, Clinics) - Global Forecast to 2023The global veterinary equipment and disposables market is projected to 2.40 billion by 2023 from USD 1.63 billion in 2018, at a CAGR of 8.0% during the forecast period of 2018 to 2023. Rising animal health expenditure and a growing demand for pet insurance, increasing number of veterinary practitioners in developed regions, and growth in the companion animals market are the primary drivers for the global veterinary equipment and disposables market during the forecast period. The prominent players in the veterinary equipment and disposables market are Mindray Medical International Limited (China), Smiths Group plc (UK), Nonin Medical (US), Digicare Biomedical Technology, Inc. (US), B. Braun Melsungen AG (Germany), Henry Schein (US), Vetland Medical Sales and Services, LLC (US), Hallowell Engineering & Manufacturing Corporation (US), Infiniti Medical, LLC (US), DRE Veterinary (US), and Midmark Corporation (US). |
August 2018 | $ 5650 |
|
Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Technology (Fluorescence Immunoassay, Radioimmunoassay, GCMS), Class of drugs (Antibiotics, Bronchodilators), End User (Hospital Lab) - Global Forecast to 2023The therapeutic drug monitoring market is projected to reach to reach USD 1.63 billion by 2023 from USD 1.16 billion in 2017 at a CAGR of 5.9% during the forecast period. The scope of the study includes the various consumables and equipment’s used to perform therapeutic drug monitoring assays. The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023. The key players operating in the TDM market are F. Hoffmann-La Roche (Switzerland), Siemens Healthineers (Germany), and Abbott (US). |
August 2018 | $ 5650 |
|
Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Leukopak (Mobilized, Non-Mobilized, Human Primary Cells), Application (Research, Therapeutic), End User (Hospitals, Research Institute) - Global Forecast to 2023The global leukapheresis products market is projected to reach USD 27.7 million by 2023 from USD 19.4 million in 2018, at a CAGR of 7.4%. Leukopaks are enriched leukapheresis products that contain higher concentrations of leukocytes. The global leukopaks market is projected to reach USD 445.6 million by 2023, at a CAGR of 46.4%. Factors contributing to the growth of these markets include the increasing incidence and prevalence of leukemia, growing demand for leukopaks for research applications, and increasing blood donations. The report analyzes the global leukapheresis products market by type, application, end user, and region. Some prominent players in the leukopaks market are HemaCare (US), AllCells (US), StemExpress (US), PPA Research Group (US), Key Biologics (US), Caltag Medsystem (UK), ZenBio (US), Precision for Medicine (US), and BioIVT (US). |
August 2018 | $ 5650 |
|
Hemodynamic Monitoring Systems Market by Product (Disposables and Monitors), Type (Invasive, Minimally Invasive, and Non-invasive), End User (Hospitals, Clinics & Ambulatory Care Center, and Home Care Setting), and Region - Global Forecasts to 2023The hemodynamic monitoring systems market is expected to reach USD 1,167.4 million by 2023 from USD 857.8 million in 2018, at a CAGR of 6.4% during the forecast period. The growth of this market is primarily driven by factors such as the technological advancements in hemodynamic monitoring systems, increasing research into hemodynamic monitoring systems, influx of VC funding, and the rising prevalence of cardiovascular diseases & diabetes. The key players in the global hemodynamic monitoring systems market are Edwards Lifesciences Corporation (US), PULSION Medical Systems SE (Germany), LiDCO Group plc (UK), Cheetah Medical (Israel), Deltex Medical Group Plc. (UK), ICU Medical (US), Osypka Medical GmbH (Germany), CareTaker Medical (US), CNSystems (Austria), NI Medical (Israel), and Uscom (Australia). |
August 2018 | $ 5650 |
|
Trocars Market by Product (Disposable, Reusable, Reposable), Tip (Bladeless Trocars, Bladed Trocars, Blunt Trocars, Optical), Application (General Surgery, Urology, Pediatric, Gynecological Surgery), End User (Hospitals) - Global Forecast to 2023The global trocars market is expected to reach USD 763.2 million by 2023 from USD 538.5 million in 2018, at a CAGR of 7.2%. The major factors driving the growth of this market are the increasing prevalence of cancer and hernia and growing preference for minimally invasive surgery. Key players in the trocars market include Medtronic (Ireland), Ethicon (US), B. Braun (Germany), Applied Medical (US), Cooper Companies (US), Teleflex (US), ConMed (US), LaproSurge (UK), Purple Surgical (UK), and GENICON (US). |
August 2018 | $ 5650 |
|
Hyperspectral Imaging System Market by Product (Camera, Accessories) & Application (Military, Remote Sensing, Environmental Monitoring, Agriculture, Mineral Map, Machine Vision/Optical Sorting, Life Sciences & Medical Diagnosis) - Global Forecast to 2023The global hyperspectral imaging systems market is projected to reach USD 21.33 billion by 2023 from USD 9.51 billion in 2018, at a CAGR of 17.5%. The growing industrial applications of hyperspectral imaging and increasing funding & investments are the major factors driving the growth of the global hyperspectral imaging systems market. The global hyperspectral imaging system market is highly competitive and fragmented. The prominent players operating in this market include Headwall Photonics (US), Applied Spectral Imaging (US), Corning Incorporated (US), Surface Optics Corporation (US), Norsk Elektro Optikk (Norway), Resonon (US), SPECIM (Finland), TELOPS (Canada), BaySpec (US), Cubert (Germany), and ChemImage (US). |
August 2018 | $ 5650 |
|
Breast Cancer Liquid Biopsy Market by Circulating Biomarkers, Region, End User, Investments, Market Dynamics, Platform Comparison (NGS, PCR), Competitive Landscape (Acquisition, Mergers, Collaboration, Competitive technology) - Global Forecasts to 2022The global breast cancer liquid biopsy market is projected to reach USD 411.1 million by 2022 from USD 145.4 million in 2017, at a CAGR of 23.1%. Factors such as increasing prevalence of breast cancer, increasing preference for noninvasive procedures, initiatives undertaken by government and global health organizations, technological advancements to augment market revenues, rising emphasis on personalized medicine in clinical practice, and increased funding for liquid biopsy R&D are driving the growth of the breast cancer liquid biopsy market. The key players in the global breast cancer liquid biopsy market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US), Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDx Health SA (US). |
August 2018 | $ 5650 |
|
Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular diseases, Psoriasis, Migraine), Type (Disposable, and Reusable), End Users (Homecare, and Hospitals) - Global Forecast to 2023The global autoinjectors market is projected to reach USD 85.31 billion by 2023 from USD 28.91 billion in 2018 at a CAGR of 24.2% during the forecast period. The growth of this market is primarily driven by factors such as the growing prevalence of targeted therapies, rising incidence of anaphylaxis, increasing number of regulatory approvals, and the availability of generic versions of autoinjectors. The key players in the global autoinjectors market are Abbvie (US), Amgen (US), Teva (Israel), Biogen (US), Eli Lilly (US), and Mylan (US). The other prominent players in the market are J&J (US), Novartis (Switzerland), Bayer (Germany), Merck (Germany), Biogen (US), Ypsomed (Switzerland), SHL Group (Taiwan) Becton, Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), and Haselmeier (Switzerland). |
August 2018 | $ 5650 |
|
Medical Robots Market by Product (Instruments & Accessories, Medical Robotic Systems (Surgical Robots, Rehabilitation Robots, Non-invasive Radiosurgery Robots)), Application (Laparoscopy, Pharmaceutical Applications), and Region - Global Forecasts to 2023The medical robots market is projected to reach USD 16.74 billion by 2023 from an estimated USD 6.46 billion in 2018. The major influencing factors driving the growth of this market are technological advancements in medical robots, advantages offered by robot-assisted training in rehabilitation therapy, increase in funding for medical robot research, and the issuance of IPOs by medical robot companies. Intuitive Surgical (US), Stryker Corporation (US), and Mazor Robotics (Israel) are the key players in the medical robots market. Other players involved in this market include Hocoma (Switzerland), Hansen Medical (US), Accuray (US), Omnicell (US), ARxIUM (Canada), and Ekso Bionics Holdings (US). |
July 2018 | $ 5650 |
|
Medical Exoskeleton Market by Component (Hardware (Sensor, Actuator, Control System, Power Source), Software), Type (Powered, Passive), Extremities (Lower, Upper) & Mobility (Mobile, Stationary) - Global Forecast to 2023The global medical exoskeleton market is projected to reach USD 571.6 million by 2023 from USD 116.7 million in 2018, at a CAGR of 37.4% during the forecast period. Factors such as the increasing number of people with physical disabilities and subsequent growth in the demand for effective rehabilitation approaches and increasing insurance coverage for medical exoskeletons in several countries are driving the growth of the medical exoskeleton market. The report segments the market into component, type, mobility, extremity, and region. The medical exoskeleton market includes various players. Key players in this market include The major players in the market are Ekso Bionics Holdings, Inc. (US), ReWalk Robotics Ltd (Israel), Parker Hannifin Corp (US), Bionik Laboratories Corp (Canada), CYBERDYNE Inc. (Japan), Rex Bionics Ltd. (UK), B-TEMIA Inc. (Canada), Hocoma AG (A Subsidiary of DIH Technologies) (Switzerland), Wearable Robotics SRL (Italy), Gogoa Mobility Robots SL (Spain), and ExoAtlet, O.O.O. (Russia). |
July 2018 | $ 5650 |
|
Veterinary Diagnostics Market by Product (Instruments, Consumables),Technology (Clinical Biochemistry, Urinalysis, Immunodiagnostics, Hematology, Molecular Diagnostics), Animal (Dogs, Cats, Horses, Cattle, Pigs, Poultry), End User - Global Forecast to 2023The veterinary diagnostics market is projected to reach USD 4.00 billion by 2023 from USD 2.63 billion in 2018, at a CAGR of 8.8%. Factors such as growing companion animal population, growing prevalence of animal zoonotic diseases, rising demand for animal-derived food products, rising demand for pet insurance & growing animal health expenditure, and the increasing number of veterinary practitioners and income levels in developed economies are expected to drive the growth of the veterinary diagnostics market. However, the increasing pet care costs may restrain the growth of the market. The major players in the veterinary diagnostics market are IDEXX Laboratories, Inc. (US), Abaxis, Inc. (US), Heska Corporation (US), Zoetis, Inc. (US), Neogen Corporation (US), Thermo Fisher Scientific, Inc. (US), QIAGEN N.V. (Netherlands), Virbac (France), bioMérieux SA (France), IDvet (France), and Randox Laboratories Ltd. (UK). |
July 2018 | $ 5650 |
|
Bowel Management Systems Market by Product (Irrigation Systems, Nerve Modulation Devices, Colostomy Bags, and Accessories), Patient Type (Adult and Pediatric), End User (Home Care and Hospitals, Ambulatory Surgery Center) - Global Forecast to 2023The global bowel management systems market is projected to reach USD 2.07 billion by 2023 from USD 1.74 billion in 2018, at a CAGR of 3.5%. Growth in the bowel management systems market is mainly driven by factors such as the expanding target patient population, the rapidly growing geriatric population, availability of technologically advanced bowel management products, and the favorable reimbursement scenario in developed countries. Some of the major players operating in the bowel management systems market are Coloplast (Denmark), Medtronic (Ireland), 3M (US), B. Braun (Germany), C.R. Bard (US), Consure Medical (India), Cogentix Medical (US), Aquaflush Medical Limited (UK), Axonics Modulation Technologies (US), ConvaTec (UK), Hollister (US), MBH-International A/S (Denmark), Mederi Therapeutics Inc. (US), Welland Medical limited (UK), and Wellspect HealthCare (Sweden). |
July 2018 | $ 5650 |
|
Biosurgery Market by Product (Fibrin & Collagen Sealant, Hemostats, Adhesion Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft Substitutes) Application (Orthopedic, Gynecology, Cardiovascular, Reconstructive) - Forecast to 2023The global biosurgery market is projected to reach USD 15.58 billion by 2023 from USD 11.36 billion in 2018, at a CAGR of 6.5%. The growth of this market is driven by the growing geriatric population and corresponding chronic diseases, increasing volume of surgeries and prevalence of severe trauma injuries, and rising need for effective blood loss management in patients. The key players in the global biosurgery market are Johnson & Johnson (US), Sanofi (France), Baxter (US), C.R. Bard (US), Integra LifeSciences (US), MAQUET (Sweden), Medtronic (Ireland), Cohera Medical (US), Hemostasis (US), Stryker(US), B.Braun (Germany), CSL (Australia), Pfizer (US), and CryoLife (US). |
July 2018 | $ 5650 |
|
Artificial Tendons and Ligaments Market by Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries, Spine Injuries, and Hip Injuries), and Region (North America, Europe, Asia Pacific, Rest of the World) - Global Forecast to 2023The global artificial tendons and ligaments market is projected to reach USD 35.0 million by 2023 from USD 18.5 million in 2018, at a CAGR of 13.6%. The growth of this market is primarily driven by factors such as the increasing incidence of sports injuries, growing number of initiatives to increase the awareness about artificial tendons and ligaments, increasing research activities on artificial tendons and ligaments, increasing preference for minimally invasive surgeries, benefits of artificial tendons and ligaments, and the issues related to the use of orthobiologics. The key players in the global artificial tendons and ligaments market are LARS (France), Neoligaments (UK), Cousin Biotech (France), Orthomed S.A.S. (France), FX Solutions (France), Shanghai PINE&POWER Biotech (China), and Mathys AG Bettlach (Switzerland). |
July 2018 | $ 5650 |
|
Fertility Test Market by Product (Ovulation Predictor Kits, Fertility Monitors (Urine & Saliva-based)), Mode of Purchase (OTC, Prescription), Application (Female, Male), End User (Home care, Fertility clinics, Hospital) - Global Forecast to 2023The global fertility test market is expected to reach 583.1 million by 2023 from USD 411.8 million in 2018, at a CAGR of 7.2%. Growth in the fertility test market can be attributed to factors, such as increasing first-time pregnancy age, launch of advanced, easy-to-use fertility monitors with high accuracy, and increasing awareness about fertility testing. The major players operating in the fertility test market include SPD Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), and Prestige Brands Holdings, Inc. (US), among others. |
July 2018 | $ 5650 |
|
Airway Management Devices Market by Type (Supraglottic Device (LMA & Oropharyngeal Airway), Infraglottic Device (Tracheostomy Tube and ET Tube), Resuscitators, Laryngoscope), End User (OR & ICU), Patient Age (Adult and Pediatric) - Global Forecast to 2023The global airway management devices market is projected to reach USD 2.10 billion by 2023 from an estimated USD 1.60 billion in 2018, at a CAGR of 5.6% during the forecast period. The growth of this market is majorly driven by factors such as rising prevalence of chronic respiratory diseases, increasing demand for emergency care, and high incidence of preterm babies are driving the growth of this market. The key players in the global airway management devices market are Medtronic (Ireland), Smiths Medical (US), Teleflex (US), Ambu (US), KARL STORZ (Germany), Flexicare (US), Verathon (US), Olympus (Japan), Intersurgical (UK), SunMed (US), Vyaire Medical (US), and VBM Medizintechnik (Germany). |
July 2018 | $ 5650 |
|
Veterinary Endoscopy Market by Product Type (Flexible, Videoscope, Fibreoptic, Rigid), Procedure (Bronchoscopy, Laparoscopy, Gastroduodenoscopy, Colonoscopy, Rhinoscopy), Animal (Companion, Large), End User (Hospitals, Clinics) - Global Forecast to 2023The global veterinary endoscopy market is expected to reach USD 219.0 million by 2023 from USD 159.8 million in 2018, at a CAGR of 6.5%. The market growth is primarily driven by the growing pet population, increasing number of pet health insurance, and advanced applications of veterinary endoscopes. Key players in the veterinary endoscopy market include KARL STORZ (Germany), Olympus (Japan), Fujifilm (Japan), Eickemeyer (Germany), B. Braun (Germany), STERIS (UK), Endoscopy Support Services (US), Biovision Veterinary Endoscopy (US), Welch Allyn (US), and Dr. Fritz (Germany). |
July 2018 | $ 5650 |
|
Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Stem Cell), End User (Hospital) – Global Forecast to 2023The global transplant diagnostics market is projected to reach USD 4.91 billion by 2023 from USD 3.44 billion in 2018, at a CAGR of 7.4%. The growth witnessed by transplant diagnostics is mainly driven by the increasing public-private funding for target research activities, growing burden of infectious diseases, increasing number of transplant procedures, and technological advancements in the field of transplant diagnostics. Major players operating in the market include Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific Inc. (US), and bioMérieux S.A. (France). Other prominent players present in this market are Immucor, Inc. (US), Illumina, Inc. (US), Luminex Corporation (US), CareDx (US), Becton, Dickinson and Company (US), Hologic (US), and GenDx (Netherlands). |
June 2018 | $ 5650 |
|
Microbiology Testing/Clinical Microbiology Market by Application (Pharma, Clinical, Manufacturing, Environment), Disease (Respiratory Disease, STD, UTI), Product (Instrument, Analyzer, Reagent), End User (Hospital, Diagnolab, Academia) - Global Forecast to 2023The global clinical microbiology market is expected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018, growing at a CAGR of 6.4%. The technological advancements in disease diagnostics, rising incidence of infectious diseases and growing outbreak of epidemics, and increased funding and public-private investments in the field of disease diagnosis are the key factors driving the growth of this market. The major players operating in the microbiology testing/clinical microbiology market include bioMérieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche AG (Switzerland), Bruker Corporation (US), Hologic, Inc. (US), QIAGEN N.V. (The Netherlands), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Shimadzu Corporation (Japan), 3M Company (US), and Neogen Corporation (US), among others. |
June 2018 | $ 5650 |
|
Dental 3D Printing Market by Product (Material (Plastic, Metal), Equipment (3D Printer, 3D Scanner), Service), Technology (Stereolithography, FDM, SLS, Polyjet), Application (Prosthodontics, Implantology, Orthodontic), End User - Global Forecast to 2023The global dental 3D printing market is projected to reach USD 5.06 billion by 2023 from USD 1.78 billion in 2018, at a CAGR of 23.2%. Market growth can be attributed to the increasing adoption of the dental 3D printers in dental hospitals and clinics, the significant increase in the geriatric population, and increasing disposable income is leading to the increased dental expenditure resulting in the utilization of digital dentistry. However, reimbursement scenario and stringent regulatory process for the approval of 3d printing equipment may hinder the growth of this market during the forecast period. The key players in the global dental 3D Systems (US), Stratasys (US/Israel), Renishaw (UK), Roland DG (Japan), SLM Solutions (Germany), EnvisionTEC (Germany), DENTSPLY Sirona (US), Straumann (Switzerland), Formlabs (US), Prodways Group (France), EOS (Germany), Rapid Shape (Germany), DWS (Italy), Planmeca (Finland), Kulzer GmbH (Germany), Ultimaker (Netherlands), Dental Wings (Canada), Carbon (US), and Asiga (Australia). |
June 2018 | $ 5650 |
|
Dental Sterilization Market by Product (Sterilization Equipment (high temperature, Low temperature), Ultrasonic Cleaner, Washer Disinfector, Surface Disinfectant, Instrument Disinfectant, Lubricant, Cleaning Solutions), End User - Global Forecast to 2023The global dental sterilization market is projected to reach USD 1.48 Billion by 2023 from USD 1.01 Billion in 2017 at a CAGR of 6.6% during the forecast period. Growth in the dental sterilization market is mainly driven by factors such as the increasing number of dental facilities and the growing pool of dental care personnel, growing prevalence of dental ailments, and increasing demand for cosmetic dentistry. The prominent players in the dental sterilization market are Getinge (Sweden), Midmark (US), SciCan (Canada), Tuttnauer (US), Planmeca (Finland), DENTSPLY Sirona (US), Danaher (US), Matachana (Spain), A-dec (US), W&H (Austria), Hu-Friedy (US), and NAKANISHI (Japan). New product launches and acquisitions were the major strategies adopted by these payers to maintain their positions in the dental sterilization market. |
June 2018 | $ 5650 |
|
Sinus Dilation Devices Market by Product (Balloon Dilation, Stents, Endoscope (Rhinoscopy, Sinoscopy), Handheld), Procedure (Standalone, Hybrid), Patient Type (Adult, Pediatric), Patient Care Setting (ENT, Clinic, Hospitals, ASC) - Global Forecast to 2023The global sinus dilation devices market is expected to reach USD 2.78 Billion by 2023 from USD 1.80 Billion in 2018, at a CAGR of 9.1% during the forecast period. Factors such as growing preference for minimally invasive procedures, benefits of balloon sinuplasty/sinus dilation over conventional sinus surgeries, favorable reimbursement scenario for sinus procedures in developed countries and high prevalence of chronic sinusitis are driving the growth of this market. The report segments the global sinus dilation devices market into product, type of procedure, patient care setting, type of patient, and region. The sinus dilation devices market includes various small and large players. Key players in this market include Entellus Medical Inc. (a subsidiary of Stryker) (US), Acclarent Inc. (a subsidiary of Johnson & Johnson) (US), Medtronic plc (Ireland), Smith & Nephew plc (UK), Intersect ENT Inc. (US), and Olympus Corporation (Japan). Other players in the market include Meril Life Sciences Pvt. Ltd. (India), SinuSys Corporation (US), InAccel (India), Jilin Coronado Medical Ltd. (China), and Creganna Medical (Ireland). |
June 2018 | $ 5650 |
|
Hematology Analyzers and Reagents Market by Products & Services (Hematology Analyzers (5 Parts, 6 Parts, 3 Part, PoC, Semi-Automated), Hemostasis, Immunohematology), Price Range (High, Low), End User (Government labs) - Global Forecast to 2023The hematology products market is projected to reach USD 4.98 Billion by 2023 from USD 3.31 Billion in 2018, at a CAGR of 8.5% during the forecast period. Factors such as the growth in blood donations, increasing incidence of blood disorder, and technological advancements in hematology analyzers and reagents are driving the growth of the market. The major players of the global hematology analyzers and reagents market are Sysmex (Japan), Danaher (US), Nihon Kohden (Japan), Siemens (Germany), Abbott Laboratories (US), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), and Roche (Switzerland). |
June 2018 | $ 5650 |
|
Dental Surgical Instruments Market by Product (Handheld Instruments, Laser, Dental Handpiece, Ultrasonic Instruments, Consumables), Therapeutic Area (Restorative Dentistry, Orthodontics), Patient Care Setting (Clinic, Hospital) - Global Forecast to 2023The global dental surgical instruments market is projected to reach USD 5.96 billion by 2023 from USD 4.48 billion in 2018, at a CAGR of 5.9%. Factors such as the rising incidence of dental diseases, growing demand for cosmetic dentistry, increasing number of dental practitioners and dental clinics, and growing dental expenditure are expected to drive market growth during the forecast period. The key players in the global dental surgical instruments market are DENTSPLY Sirona Inc. (US), Danaher Corporation (US), 3M Company (US), COLTENE Holding AG (Switzerland), Brasseler USA, A-dec, Inc. (US), Hu-Friedy Manufacturing Company, LLC (US), Integra LifeSciences Holdings Corporation (US), NAKANISHI Inc. (Japan), BIOLASE, Inc. (US), The Yoshida Dental Mfg. Co., Ltd. (Japan), Helmut Zepf Medizintechnik GmbH (Germany), Prima Dental Manufacturing Ltd. (UK), B. Braun Melsungen AG (Germany), AMD Lasers (US), and CAO Group, Inc. (US). |
June 2018 | $ 5650 |
|
Vascular Patches Market by Material (Biologic, Synthetic), Application (Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysms, Vascular Bypass Surgery), Patient Care Setting (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2023The global vascular patches market is expected to reach USD 525.8 Million by 2023 from USD 349.6 Million in 2018, at a CAGR of 8.5%. Growth in the vascular patches market is mainly driven by the rapidly growing geriatric population and the subsequent increase in the prevalence of vascular diseases, the increasing number of vascular surgeries performed, and the increasing adoption of biological patches. Major vendors who provide eDiscovery software and services include AccessData (US), Advanced Discovery (US), Catalyst (US), CloudNine (US), Commvault (US), Conduent (US), Deloitte (US), Driven (US), Epiq (US), FRONTEO (Japan), FTI (US), IBM (US), Ipro (US), KLDiscovery (US), Lighthouse (US), Logikcull (US), Micro Focus (UK), Microsoft (US), Nuix (Australia), OpenText (Canada), Relativity (US), Ricoh (Japan), Thomson Reuters (Canada), Veritas (US), and ZyLAB (Netherlands. |
June 2018 | $ 5650 |
|
Cold Pain Therapy Market by Product (OTC (Gels, Sprays, Patches, Cold Packs, Wraps, Pads, and Roll-Ons), Prescription-Based (Motorized, Non-Motorized Devices), Applications (Musculoskeletal Disorders, Post-Operative Therapy, Sports Medicine, and Post-Trauma Therapy) - Global Forecast to 2023The global cold pain therapy market is projected to reach USD 2.12 Billion by 2023 from USD 1.69 Billion in 2018, at a CAGR of 4.6%. The increasing incidence of sports injuries and rising emphasis on exercise and gym activities, growing number of hip and knee surgeries across the globe, and growing need for safer pain management modalities as opposed to oral drug therapy are expected to drive the demand for cold pain therapy products during the study period. As of 2017, the major players in the cold pain therapy market are Sanofi (France), DJO Finance (US), and Pfizer (US). Other players in this market include 3M (US), Hisamitsu Pharmaceutical (Japan), Johnson & Johnson (US), Medline Industries (US), Össur (Iceland), Performance Health (US), Beiersdorf (Germany) Rohto Pharmaceutical (US), Breg (US), Romsons Group of Industries (India), Custom Ice (US), and Unexo Life Sciences (India). |
June 2018 | $ 5650 |
|
Sterilization Equipment Market by Product & Service (Instrument (Heat, Filtration, Low Temperature), Consumables and Accessories (Detergents, Indicators), Services (E beam, Gamma)), End User (Hospitals, Pharmaceutical Companies) - Global Forecast to 2023The global sterilization equipment market is expected to reach USD 11.14 Billion by 2023 from USD 7.94 Billion in 2018, at a CAGR of 7.0%. The major factors driving the growth of this market are the rising incidence of hospital-acquired infections, increasing number of surgical procedures, rising focus on food sterilization and disinfection, technological advancements in sterilization equipment, and increasing number of hospitals in Asia. Key players in the sterilization equipment market include Steris Corporation (US), Getinge Group (Sweden), Advanced Sterilization Products (US), 3M Company (US), Belimed AG (Switzerland), Cantel Medical (US), and Sterigenics International, Inc. (US) |
June 2018 | $ 5650 |
|
Angiography Equipment Market by Product (Angiography Systems, Catheters, Guidewire, Balloons, Contrast Media), Technology (X-Ray, CT, MRA), Procedure (Coronary, Endo, Neuro), Application (Diagnostic, Therapeutic), Patient Care Setting - Global Forecast to 2023The angiography equipment market is projected to reach USD 13.06 Billion by 2023 from USD 10.26 Billion in 2018, at a CAGR of 5.0%. The growth in this market is attributed to the high prevalence of diseases such as cancer and CVDs, increasing product approvals for advanced angiography techniques in the market, the large number of ongoing research activities, growing government and public-private investments, increasing number of awareness programs, and rising adoption of angiography devices due to a large number of angiography procedures performed across the globe. The key players in the angiography equipment market are GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Canon Corporation (Japan), Boston Scientific Corporation (US), Cordis (a Cardinal Health Company, US), Shimadzu Corporation (Japan), Medtronic (Ireland), Angiodynamics (US), B. Braun Melsungen (Germany), and Abbott Laboratories (US). |
June 2018 | $ 5650 |
|
Wound Care Biologics Market by Product (Biological Skin Substitutes (Biosynthetic Products), Topical Agents), Wound Type (Diabetic Foot Ulcer, Pressure Ulcers, Surgical & Traumatic Wound), End User (Hospitals, Burn Centers) - Global Forecast to 2023The global wound care biologics market is expected to reach USD 2.26 Billion by 2023 from USD 1.42 Billion in 2018, at a CAGR of 9.8%. Market growth is mainly driven by factors such as the increasing incidence of diabetic foot ulcers, increasing geriatric population, and increasing burn injuries globally. On the other hand, the high cost of wound care biologics and the higher rejection rate associated with skin grafts & substitutes will restrain the growth of this market. Key players in the wound care biologics market include Smith & Nephew (UK), Mölnlycke Health Care AB (Sweden), Integra LifeSciences Corporation (US), Wright Medical (US), MiMedx Group (US), Vericel Corporation (US), Anika Therapeutics (US), Osiris Therapeutics (US), Organogenesis (US), Kerecis (Iceland), Solsys Medical (US), ACell (US), Lavior Inc. (US), and Marine Polymer Technologies, Inc. (US). |
June 2018 | $ 5650 |
|
Lithotripsy Devices Market by Type (ESWL, Intracorporal (Laser, Electrohydraulic, Mechanical, Ultrasonic Lithotripsy)), Application (Kidney, Ureteral, Bile Duct & Pancreatic Stones), End User (Hospital), Procedures - Global Forecast to 2023The global lithotripsy devices market is expected to reach USD 1.76 Billion by 2023 from USD 1.41 Billion in 2018, at a CAGR of 4.5%. Growth in this market is propelled by the increasing incidence of urolithiasis and technological advancements in lithotripsy devices. Some of the major players in the lithotripsy devices market are Siemens AG (Germany), Boston Scientific (US), Dornier MedTech (Germany), Olympus America (Japan), DirexGroup (Germany), and Richard Wolf (Germany). Key companies in the lubricating oil additives market include Afton Chemical (US), Chevron Oronite (US), BASF (Germany), Evonik Industries (Germany), Lubrizol Corporation (US), and Lanxess (Germany). |
June 2018 | $ 5650 |
|
Wound Debridement Market by Product (Gels, Ointments, Surgical, Ultrasonic Devices), Method (Autolytic, Enzymatic, Mechanical), Wound Type (Venous Leg, Diabetic Foot, Pressure Ulcers, Burns), End User (Hospitals, Clinics) - Global Forecast to 2023The global wound debridement market is expected to reach USD 1,041.0 Million by 2023 from USD 702.0 Million in 2018, at a CAGR of 8.2%. Factors such as rising incidence of diabetes & associated wounds, growing aging population, rising incidence of burn injuries, and growing awareness programs for wound care treatment and management are driving the growth of the wound debridement market. The major players in the wound debridement market include Smith & Nephew (UK), B. Braun Melsungen AG (Germany), Coloplast (Denmark), Misonix (US), ConvaTec (UK), Lohmann & Rauscher (Germany), DeRoyal Industries (US), Medline Industries (US), Mölnlycke Health Care AB (Sweden), and Integra LifeSciences (US). |
May 2018 | $ 5650 |
|
Hernia Repair Market by Product (Mesh (Synthetic, Biologic), Mesh Fixation (Suture, Tack and Glue Applicator)), Surgery Type (Inguinal, Incisional/Ventral, Umbilical, Femoral), and Geography (America, Europe, Asia Pacific) - Forecast to 2023The hernia repair market is projected to reach USD 4.75 Billion by 2023 from USD 4.09 Billion in 2018, at a CAGR of 3.0% during the forecast period. The increasing adoption of mesh in hernia repair surgeries, rising geriatric population, new product developments, and efficient reimbursement system in developed countries are the major factors driving the growth of the hernia repair market during the forecast period. The major players in the hernia repair market profiled in this report are Covidien ( Part of Medtronic) (Ireland), Ethicon (Part of Johnson & Johnson) (US), B. Braun (Germany), C.R. Bard (Part of Becton Dickinson) (US), W. L. Gore (US), LifeCell (Part of Allergan) (Ireland), Maquet (Part of Getinge) (Sweden), Cook Medical (US), Integra (US), DIPROMED (Italy), FEG (Germany), Cousin Biotech (France), Herniamesh (Italy), Aspide Medical (France), TransEasy Medical (China), and Via Surgical (Israel). |
May 2018 | $ 5650 |
|
Bariatric Surgery Devices Market by Type (Minimally Invasive (Stapling, Suturing), Non-Invasive), Procedure (Sleeve Gastrectomy, Gastric Bypass, Revision Surgery, Adjustable Gastric Banding, Mini Gastric Bypass) - Global Forecast to 2023The global bariatric surgery devices market is projected to reach USD 2.16 Billion by 2023 from USD 1.64 Billion in 2018, at a CAGR of 5.7% during the forecast period. The growth of this market is driven by factors such as the growing obese population, increasing number of bariatric surgeries, and increasing preference for minimally invasive procedures. Ethicon (US), Medtronic (Ireland), Intuitive Surgical (US), Apollo Endosurgery (US), and ReShape Lifesciences, (US) are the key players in the bariatric surgery devices market. Other players involved in this market are Aspire Bariatrics (US), Mediflex Surgical Products (US), Spatz FGIA (US), Cousin Biotech (France), and Olympus Corporation of the Americas (US). |
May 2018 | $ 5650 |
|
Molecular Diagnostics Market by Application (Infectious Disease (Hepatitis, HIV), Oncology, Genetic Testing), Technology (PCR, DNA Sequencing & NGS), End User (Hospital/Academic Laboratory), Product & Service (Reagent, Software) - Global Forecast to 2023The global molecular diagnostics market is projected to reach USD 11.54 Billion by 2023 from USD 7.10 Billion in 2017, at a CAGR of 8.4%. The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023. Growth in this market is primarily driven by the high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular techniques. The key players in the global molecular diagnostics market are Roche (Switzerland), Hologic (US), QIAGEN (Netherlands), Abbott (US), and Danaher (US). |
May 2018 | $ 5650 |
|
Patient Monitoring Devices Market by Product (EEG, EMG, MEG, TCD, Peak Flow Meter, Pulse Oximeter, Fetal Monitoring, Temperature Monitoring Devices, MCOT, ECG, Hemodynamic Monitoring System), End User (Home, Hospital) - Global Forecast to 2023The patient monitoring devices market is projected to reach USD 25.31 Billion by 2023 from USD 19.14 Billion in 2018, at a CAGR of 5.7%. Factors such as the easy availability of wireless monitoring devices and the rising incidence of lifestyle and chronic diseases are expected to drive market growth during the forecast period. The patient monitoring devices market is dominated by players such as Medtronic (Ireland), Abbott (US), Natus Medical (US), Nihon Kohden (Japan), GE Healthcare (US), and Philips Healthcare (Netherlands). |
May 2018 | $ 5650 |
|
Adhesion Barrier Market by Product (Regenerated Cellulose, Hyaluronic Acid, Polyethylene Glycol, Fibrin, Collagen & Protein), Type (Film, Gel, Liquid), Application (Abdominal, Orthopedic, Cardiovascular, Gynecological Surgery) - Global Forecast to 2023The global adhesion barrier market is projected to reach USD 806.4 Million by 2023 from USD 570.7 Million in 2018, at a CAGR of 7.2%. The growth of this market is driven by the growth in the geriatric population and corresponding age-related chronic diseases, epidemiological shift from infectious to chronic diseases, growing volume of surgical procedures and sports-related injuries, and increasing awareness about the medical complications occurred due to post-surgical adhesion formation. The key players in the global adhesion barrier market are Johnson & Johnson (J&J) (US), Sanofi (France), Baxter International (US), C.R. Bard (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll Holdings (Ireland), Betatech Medical (Turkey), SyntheMed (US), Aziyo Biologics (US), Biom’up (France), Terumo Corporation (Japan), and BMI Korea Co. (South Korea). |
May 2018 | $ 5650 |
|
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.
Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement
Connect With Us
Live Chat Support
Search reports
Medical Devices ›
Information and Communications Technology ›
Semiconductor and Electronics ›
Chemicals ›
Advanced Materials ›
Energy and Power ›
Food and Beverage ›
Biotechnology ›
Aerospace and Defence ›
Healthcare IT ›
Automotive and Transportation ›
Automation and Process Control ›
Agriculture Industry ›
Packaging ›
Pharmaceuticals ›
Building and Construction ›
Mining, Minerals and Metals ›
Analytical and Scientific Instrumentation ›
Engineering Equipment and Devices ›
'Connect With Us
